Related Experiment Video
Updated: Feb 4, 2026

Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies
Salem Kim1, Afsaneh Barzi2, Lakshmi Rajdev1
1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.
Abstract:
Gastroesophageal malignancies often contain high amounts of genetic and molecular alterations that result in an aggressive disease capable of rapidly metastasizing to distant organs and early development of drug resistance. Most patients in the Western hemisphere present with locally advanced or metastatic disease that is treated with systemic chemotherapy used either in the neoadjuvant or palliative setting, respectively. This article will review the various recent advances in the development of targeted therapies for the treatment of advanced gastric and gastroesophageal cancer.
Insights
Advanced gastric and gastroesophageal cancers exhibit aggressive traits and drug resistance. This review explores recent progress in targeted therapies for these challenging malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Gastroesophageal malignancies are characterized by significant genetic and molecular alterations.
- These alterations contribute to aggressive disease progression, rapid metastasis, and early drug resistance.
- Many patients present with advanced or metastatic disease requiring systemic treatment.
Purpose of the Study:
- To review recent advancements in targeted therapy development for advanced gastric and gastroesophageal cancer.
- To highlight novel therapeutic strategies beyond traditional chemotherapy.
Main Methods:
- Literature review of recent studies and clinical trials.
- Analysis of emerging targeted therapies and their mechanisms of action.
- Synthesis of data on targeted agents for advanced gastric and gastroesophageal cancer.
Main Results:
- Identification of several promising targeted therapies currently in development or clinical use.
- Discussion of specific molecular targets and associated drug candidates.
- Overview of the potential impact of targeted therapies on patient outcomes.
Conclusions:
- Targeted therapies represent a significant advancement in treating advanced gastric and gastroesophageal cancers.
- Further research and clinical trials are crucial to optimize the use of these novel agents.
- Personalized medicine approaches hold promise for improving treatment efficacy and patient survival.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Esophageal Varices-I: Introduction
P-N junction
Gastric Emptying
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....

